Amphiphilic Indole Derivatives as Antimycobacterial Agents: Structure–Activity Relationships and Membrane Targeting Properties

2017 ◽  
Vol 60 (7) ◽  
pp. 2745-2763 ◽  
Author(s):  
Tianming Yang ◽  
Wilfried Moreira ◽  
Samuel Agyei Nyantakyi ◽  
Huan Chen ◽  
Dinah binte Aziz ◽  
...  
MedChemComm ◽  
2014 ◽  
Vol 5 (1) ◽  
pp. 86-92 ◽  
Author(s):  
Younis Baqi ◽  
Samer Alshaibani ◽  
Kirsten Ritter ◽  
Aliaa Abdelrahman ◽  
Andreas Spinrath ◽  
...  

Several tri- and tetra-substituted indole derivatives were synthesized and evaluated as human GPR17 agonists. Steep structure–activity relationships were observed.


1993 ◽  
Vol 36 (8) ◽  
pp. 1053-1068 ◽  
Author(s):  
Chiu Hong Lin ◽  
Susanne R. Haadsma-Svensson ◽  
Robert A. Lahti ◽  
Robert B. McCall ◽  
Montford F. Piercey ◽  
...  

1993 ◽  
Vol 36 (8) ◽  
pp. 1069-1083 ◽  
Author(s):  
Chiu Hong Lin ◽  
Susanne R. Haadsma-Svensson ◽  
Gillian Phillips ◽  
Robert A. Lahti ◽  
Robert B. McCall ◽  
...  

2021 ◽  
Vol 13 (20) ◽  
pp. 1795-1828
Author(s):  
Fatima Naaz ◽  
Kumari Neha ◽  
Md Rafi Haider ◽  
Syed Shafi

Tubulin inhibitors are conjugates that interfere with the dynamic equilibrium of the polymerization and depolymerization of microtubules. Among all the reported conjugates, indole moiety is one of the most significant classes for the development of new drug candidates for cancer therapy. Due to their presence in a wide range of natural as well as synthetic antitubulin agents, indole has become a versatile scaffold in research, and various synthetic and semisynthetic indole-based antitubulin agents have been identified and reported. The present article focuses on the reported indole-based tubulin inhibitors of synthetic origin from last the decade. Synthesis, structure–activity relationships and biological activities of synthetic indole derivatives along with brief updates on their antitubulin activity are presented.


Sign in / Sign up

Export Citation Format

Share Document